Disparities in COVID-19 clinical studies from high-income and low-and middle-income countries.

ABSTRACT:

Objectives

To examine the disparities between COVID-19 studies conducted in high-income countries (HICs) and low-and middle-income countries (LMICs).

Methods

We used the International Clinical Trials Registry Platform to identify COVID-19-related studies registered from December 31, 2019 to December 31, 2021. The World Bank definition was used to classify countries as high-, upper-middle-, lower-middle-, and low-income. The last three were considered to be LMICs. We examined the disparities in response speed, classification of medicines and vaccines, and registration and results reporting compliance between COVID-19 studies conducted in HICs and LMICs.

Results

We included 12,396 COVID-19 studies, with 6631 (53.5%) from HICs. HIC-registered studies reached a peak of 10

SUBMITTER: Yin S 

PROVIDER: S-EPMC10105623 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature